Restricting use of adenovirus vector-based COVID vaccines could endanger public and global health von Ertl, Hildegund C. J., Currie, Sue L., Luber, Andrew D.

Volltext

Plasma Amprenavir Pharmacokinetics and Tolerability following Administration of 1,400 Milligrams of Fosamprenavir Once Daily in Combination with either 100 or 200 Milligrams of Rit... von RUANE, Peter J, LUBER, Andrew D, WIRE, Mary Beth, YU LOU, SHELTON, Mark J, TRACEY LANCASTER, C, PAPPA, Keith A

Volltext

A therapeutic HBV vaccine containing a checkpoint modifier enhances CD8+ T cell and antiviral responses von Hasanpourghadi, Mohadeseh, Novikov, Mikhail, Ambrose, Robert, Chekaoui, Arezki, Newman, Dakota, Xiang, ZhiQuan, Luber, Andrew D, Currie, Sue L, Zhou, XiangYang, Ertl, Hildegund Cj

Volltext

Pharmacokinetic Considerations for Selection of HAART in Treatment-Naive HIV-Infected Individuals, 2008: More Than it Seems? von Luber, Andrew D.

Volltext

Genetic Barriers to Resistance and Impact on Clinical Response von Luber, Andrew D

Volltext

Treatment strategies for highly treatment-experienced HIV-infected patients von Luber, Andrew D

Volltext

Use of acid-reducing agents in protease inhibitor-based HAART and the potential for negative treatment outcomes von Luber, Andrew D

Volltext

Ceftriaxone Therapy for Staphylococcal Osteomyelitis: A Review von Guglielmo, B. Joseph, Luber, Andrew D., Paletta, Domenic, Jacobs, Richard A.

Volltext

Standard methods to measure HIV drug concentrations von Luber, Andrew D, Merry, Concepta

Volltext

Pharmacokinetic Parameters of Protease Inhibitors and the Cmin/IC50 Ratio: Call for Consensus von Becker, Stephen, Fisher, Alvan, Flexner, Charles, Gerber, John G, Haubrich, Richard, Kashuba, Angela D. M, Luber, Andrew D, Piscitelli, Stephen C

Volltext

Relative Importance of Oral versus Intravenous Vancomycin Exposure in the Development of Vancomycin-Resistant Enterococci von Luber, Andrew D., Jacobs, Richard A., Jordan, Marilyn, Guglielmo, B. Joseph

Volltext

Risk factors for amphotericin B-induced nephrotoxicity von LUBER, A. D, MAA, L, LAM, M, GUGLIELMO, B. J

Volltext

Hypothermia Following the Intravenous Administration of Amphotericin B von Barlows, Theodore G., Luber, Andrew D., Jacobs, Richard A., Guglielmo, B. Joseph

Volltext

Genetic barriers to resistance and impact on clinical response von Luber, Andrew D

Volltext

Prevention of adverse events in hospitalized patients using an antimicrobial review program von Guglielmo, B J, Luber, A D, Corelli, R L, Flaherty, J F, Jacobs, R A

Volltext

Enfuvirtide von Lalezari, Jacob P, Luber, Andrew D

Volltext

GLYCOPROTEIN D VARIANTS AS VACCINE ADJUVANTS von CURRIE, Sue L, ERTL, Hildegund CJ, LUBER, Andrew D

Volltext bestellen

GLYCOPROTEIN D VARIANTS AS VACCINE ADJUVANTS von Luber, Andrew D, Currie, Sue L, Ertl, Hildegund CJ

Volltext bestellen

GLYCOPROTEIN D VARIANTS AS VACCINE ADJUVANTS von CURRIE, Sue L, ERTL, Hildegund CJ, LUBER, Andrew D

Volltext bestellen

Pharmacokinetic Parameters of Protease Inhibitors and the Cmin/IC50 Ratio: Call for Consensus von Becker, Stephen, Fisher, Alvan, Flexner, Charles, Gerber, John G., Haubrich, Richard, Kashuba, Angela D. M., Luber, Andrew D., Piscitelli, Stephen C.

Volltext